Summary
This 8-K filing from Edwards Lifesciences Corporation (EW) reports the resignation of Carlyn D. Solomon from his role as Corporate Vice President, Critical Care and Vascular, effective October 3, 2014. Mr. Solomon is leaving to pursue an opportunity as Chief Operating Officer at another medical products company and will remain with Edwards Lifesciences for a brief transition period. This executive departure, while not necessarily indicating operational issues, represents a change in leadership for a key division. Investors should monitor how this transition impacts the Critical Care and Vascular segment's performance and strategy, and the company's plans for leadership succession in this important area.
Key Highlights
- 1Carlyn D. Solomon, Corporate Vice President, Critical Care and Vascular, resigned on October 3, 2014.
- 2Mr. Solomon is departing to accept a Chief Operating Officer position at another medical products company.
- 3He will stay with Edwards Lifesciences for a short transition period.
- 4The resignation impacts leadership within the Critical Care and Vascular division.
Frequently Asked Questions
Carlyn D. Solomon, Corporate Vice President of Critical Care and Vascular, resigned from his position.
The resignation was effective on October 3, 2014.
Mr. Solomon resigned to accept a position as Chief Operating Officer at another medical products company.
Yes, he intends to remain with Edwards Lifesciences for a brief transition period.